Literature DB >> 11765063

p53-mediated apoptosis and genomic instability diseases.

A I Robles1, C C Harris.   

Abstract

Mutations in several DExH-containing DNA helicases, including XPD, XPB, WRN, and BLM, are associated with rare familial cancer syndromes characterized by genomic instability and cancer susceptibility. Known cellular activities of these helicases include DNA replication, repair, recombination, and/or transcription. The p53 tumor suppressor is a regulator of cellular responses to stress, and is biochemically involved in the induction of cell-cycle arrest, apoptosis and DNA repair, all of which contribute to maintenance of genomic integrity. Physical and functional interactions of p53 with DExH-containing DNA helicases have been described. We propose that such interactions could be compromised in inherited disorders and contribute to their cancer susceptibility. In particular, the role of DNA helicases in p53-mediated apoptotic pathways is reviewed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11765063     DOI: 10.1080/02841860152619106

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Redundancy of DNA helicases in p53-mediated apoptosis.

Authors:  E A Spillare; X W Wang; C von Kobbe; V A Bohr; I D Hickson; C C Harris
Journal:  Oncogene       Date:  2006-03-30       Impact factor: 9.867

2.  Mannheimia haemolytica leukotoxin induces apoptosis of bovine lymphoblastoid cells (BL-3) via a caspase-9-dependent mitochondrial pathway.

Authors:  Dhammika N Atapattu; Charles J Czuprynski
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.

Authors:  Chunying Li; Kexin Chen; Zhensheng Liu; Li-E Wang; Jeffrey E Gershenwald; Jeffrey E Lee; Victor G Prieto; Madeleine Duvic; Elizabeth A Grimm; Qingyi Wei
Journal:  J Invest Dermatol       Date:  2007-11-29       Impact factor: 8.551

Review 4.  Other proteins interacting with XP proteins.

Authors:  Steven M Shell; Yue Zou
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.

Authors:  Hong-yun Wang; Gao-fei Xiong; Ji-xiang Zhang; Hong Xu; Wu-hua Guo; Jiang-jing Xu; Xiang-yang Xiong
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

6.  Association of p73 G4C14-to-A4T14 polymorphism with lung cancer risk.

Authors:  Hua Liu; Yuli Liang; Hua Liao; Lanying Li; Hongyun Wang
Journal:  Tumour Biol       Date:  2014-06-19

7.  Drosophila p53 preserves genomic stability by regulating cell death.

Authors:  Naoko Sogame; Misoo Kim; John M Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

8.  No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.

Authors:  Raju K Mandal; Suraj S Yadav; Aditya K Panda
Journal:  Tumour Biol       Date:  2014-05-28

9.  The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

Authors:  Frank Staib; Ana I Robles; Lyuba Varticovski; Xin W Wang; Barry R Zeeberg; Michail Sirotin; Victor B Zhurkin; Lorne J Hofseth; S Perwez Hussain; John N Weinstein; Peter R Galle; Curtis C Harris
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

10.  Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 protein.

Authors:  Jinwoo Ahn; Masha V Poyurovsky; Nicole Baptiste; Rachel Beckerman; Christine Cain; Melissa Mattia; Kristine McKinney; Jianmin Zhou; Andrew Zupnick; Vanesa Gottifredi; Carol Prives
Journal:  Cell Cycle       Date:  2009-05-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.